Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Genmab Announces Phase III Study of Daratumumab in Front Line Multiple Myeloma
Genmab Announces Phase III Study of Daratumumab in Front Line Multiple Myeloma
Genmab Announces Phase III Study of Daratumumab in Front Line Multiple Myeloma
Submitted by
admin
on July 19, 2014 - 9:26am
Source:
Pipeline Review
News Tags:
daratumumab
Multiple Myeloma
Headline:
Genmab Announces Phase III Study of Daratumumab in Front Line Multiple Myeloma
Do Not Allow Advertisers to Use My Personal information
